« »

INNOLABS 1st Open Call – New cross-sectorial health solutions for personalized health

HCN Project, News Item – 15 October 2017

Open call for SMEs based in a EU member state or H2020 associated country. The focus is on cross sectoral solutions for ageing populations and rural areas that incorporate mHealth technologies

INNOLABS 1st Open Call for innovative projects in personalized healthcare has been open from the 15th of June until the 30th of September 2017. The project received 117 applications from 24 different countries out of which  112 project proposals successfully passed the first eligibility check

The best 25 projects will be selected to enrol into an Acceleration Programme and receive support of up to 50,000€, while the 25 finalist projects will receive support of up to 10,000€.

The Acceleration Programme will last 9 months, from December 2017 to August 2018, and 5 projects will be allowed to enter the Fast Lane Acceleration, receiving equal support but concentrated in 3 months.

The first Open Call was open to smart health solutions based on combination of ICT, BIO, Health and Medicine sectors. Proposed solutions should solve or meet the needs of ageing populations in rural and urban areas.

THE CHALLENGES TO TACKLE

This first INNOLABS Open Call seeked proposals to address at least one of the following proposed challenges:

1. ICT and health – The challenge is to help ageing populations remain independent and active in their communities (especially rural and remote ones) with ICT-based assistive solutions. These solutions should be accessible to consumers (the silver economy) and institutional health care providers and promote participation of stakeholders in the care continuum. They also need to be interoperable and secure whether the solution is an mHealth or eHealth.

2. Biotech and health – As people age they become more susceptible to chronic diseases and co-morbidities (e.g. cancer and diabetes). The challenge is to use biotechnology to support an approach to care that is predictive, preventative and personalised. This encompasses diagnosis, prognosis, treatment options. In practical terms the benefits range from early detection of disease conditions, better informed and personalised clinical decisions in diagnosis and treatment and empowered patients with effective shared care plans.

3. Solutions generated by end-users need identification – We are seeing a shift from industry-driven products to ones that are more demand-driven by the end-user. This might involve the co-design of solutions as well as their testing. With this challenge, we are seeking solutions that builds on an original idea generated from (i) someone working within or (ii) a patient(s) treated by – a service along the health and social care continuum. In particular, we are interested in products and processes that are more affordable and less invasive.

Health ClusterNET’s Role

These challenges were identified from interviews done by HCN with Innovation Cluster partners as part of its lead role for Work Package 4 Fostering cross-chain innovations and new emerging industries.

A short lay report summarising baseline interviews with partner innovation clusters and third parties (including SME owners, health care providers, academics and senior regional government officials) will be available shortly.

 

Contact Details:

info@innolabs.io

 

INNOLABS Project Link:

http://blog.innolabs.io/innolabs-1st-open-call-112-proposals-passed/

http://innolabs.io/open-call.html

 

Follow us on:

   

 

 

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 691556.

This article reflects only the author’s view and that the European Commission is not responsible for any use that may be made of the information it contains.

Published by

Edit Sebestyen


All news